Takeda Pharmaceutical Co Ltd (NYSE:TAK)
$ 13.45 -0.11 (-0.81%) Market Cap: 42.99 Bil Enterprise Value: 70.33 Bil PE Ratio: 22.63 PB Ratio: 0.94 GF Score: 79/100

Takeda Pharmaceutical Co Ltd Finance Investor Day Transcript

Jul 12, 2021 / 11:00PM GMT
Release Date Price: $16.69 (-0.30%)
Unidentified Company Representative;Constantine Saroukos
Takeda Pharmaceutical Company Limited - CFO & Representative

Good morning. Good evening, and welcome. Thank you very much for joining Takeda Pharmaceutical's Global Finance Investor Day, a day where we would like to talk to you about how we at Takeda are creating a best-in-class finance organization by leveraging the power of data and digital. I'm [Joseph Cairnes], Senior Director of Investor Relations. I'd like to serve as the moderator today.

Before starting, I'd like to remind everyone that we will be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those discussed today. The factors that could cause our actual results to differ materially are discussed in our most recent Form 20-F and in our other SEC filings. Please also refer to the important notice on Slide 2 of the presentation today.

Now please let me hand you over to Costa Saroukos, our Chief Financial Officer, for introductory remarks.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot